Publications by authors named "Philippe Rodon"

Claim this Profile
C
Clinical characteristics and outcome of 318 families with familial monoclonal gammopathy: A multicenter Intergroupe Francophone du Myélome study.
Charles Dumontet, Delphine Demangel, Perrine Galia, Lionel Karlin, Laurent Roche, Philippe Rodon

Am J Hematol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carfilzomib maintenance in newly diagnosed non-transplant eligible multiple myeloma.
Arthur Bobin, Maéva Kyheng, Stéphanie Guidez, Cécile Gruchet-Merouze, Valentine Richez, Philippe Rodon

Leukemia· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral ixazomib, lenalidomide, and dexamethasone for transplant-ineligible patients with newly diagnosed multiple myeloma.
Thierry Facon, Christopher P Venner, Nizar J Bahlis, Fritz Offner, Darrell J White, Philippe Rodon

Blood· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exome sequencing identifies germline variants in DIS3 in familial multiple myeloma.
Maroulio Pertesi, Maxime Vallée, Xiaomu Wei, Maria V Revuelta, Perrine Galia, Philippe Rodon

Leukemia· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carfilzomib Weekly plus Melphalan and Prednisone in Newly Diagnosed Transplant-Ineligible Multiple Myeloma (IFM 2012-03): A Phase I Trial.
Xavier Leleu, Guillemette Fouquet, Valentine Richez, Stéphanie Guidez, Alain Duhamel, Philippe Rodon

Clin Cancer Res· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and Validation of a Cytogenetic Prognostic Index Predicting Survival in Multiple Myeloma.
Aurore Perrot, Valérie Lauwers-Cances, Elodie Tournay, Cyrille Hulin, Marie-Lorraine Chretien, Philippe Rodon

J Clin Oncol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apixaban for the prevention of thromboembolism in immunomodulatory-treated myeloma patients: Myelaxat, a phase 2 pilot study.
Brigitte Pegourie, Lionel Karlin, Lotfi Benboubker, Frédérique Orsini-Piocelle, Mourad Tiab, Philippe Rodon

Am J Hematol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A predictive model for risk of early grade ≥ 3 infection in patients with multiple myeloma not eligible for transplant: analysis of the FIRST trial.
Charles Dumontet, Cyrille Hulin, Meletios A Dimopoulos, Andrew Belch, Angela Dispenzieri, Philippe Rodon

Leukemia· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Salvage therapy post pomalidomide-based regimen in relapsed/refractory myeloma.
Guillemette Fouquet, Lionel Karlin, Margaret Macro, Denis Caillot, Murielle Roussel, Philippe Rodon

Ann Hematol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rituximab maintenance versus observation following abbreviated induction with chemoimmunotherapy in elderly patients with previously untreated chronic lymphocytic leukaemia (CLL 2007 SA): an open-label, randomised phase 3 study.
Caroline Dartigeas, Eric Van Den Neste, Julie Léger, Hervé Maisonneuve, Christian Berthou, Philippe Rodon

Lancet Haematol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum free light chains, not urine specimens, should be used to evaluate response in light-chain multiple myeloma.
Thomas Dejoie, Jill Corre, Helene Caillon, Cyrille Hulin, Aurore Perrot, Philippe Rodon

Blood· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Updated Outcomes and Impact of Age With Lenalidomide and Low-Dose Dexamethasone or Melphalan, Prednisone, and Thalidomide in the Randomized, Phase III FIRST Trial.
Cyrille Hulin, Andrew Belch, Chaim Shustik, Maria Teresa Petrucci, Ulrich Dührsen, Philippe Rodon

J Clin Oncol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
VTD is superior to VCD prior to intensive therapy in multiple myeloma: results of the prospective IFM2013-04 trial.
Philippe Moreau, Cyrille Hulin, Margaret Macro, Denis Caillot, Carine Chaleteix, Philippe Rodon

Blood· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding the role of hyperdiploidy in myeloma prognosis: which trisomies really matter?
Marie-Lorraine Chretien, Jill Corre, Valerie Lauwers-Cances, Florence Magrangeas, Alice Cleynen, Philippe Rodon

Blood· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of bendamustine, bortezomib and dexamethasone as second-line treatment for elderly patients with multiple myeloma: the Intergroupe Francophone du Myelome 2009-01 trial.
Philippe Rodon, Cyrille Hulin, Brigitte Pegourie, Mourad Tiab, Bruno Anglaret

Haematologica· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pomalidomide plus low-dose dexamethasone in multiple myeloma with deletion 17p and/or translocation (4;14): IFM 2010-02 trial results.
Xavier Leleu, Lionel Karlin, Margaret Macro, Cyrille Hulin, Laurent Garderet, Philippe Rodon

Blood· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MELISSE, a large multicentric observational study to determine risk factors of venous thromboembolism in patients with multiple myeloma treated with immunomodulatory drugs.
Xavier Leleu, Philippe Rodon, Cyrille Hulin, Laurent Daley, Charles Dauriac

Thromb Haemost· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The translocation t(4;14) can be present only in minor subclones in multiple myeloma.
Benjamin Hébraud, Denis Caillot, Jill Corre, Gérald Marit, Cyrille Hulin, Philippe Rodon

Clin Cancer Res· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chromosomal abnormalities are major prognostic factors in elderly patients with multiple myeloma: the intergroupe francophone du myélome experience.
Hervé Avet-Loiseau, Cyrille Hulin, Loic Campion, Philippe Rodon, Gerald Marit

J Clin Oncol· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of thalidomide in newly diagnosed elderly myeloma patients: a meta-analysis of data from individual patients in six randomized trials.
Antonio Palumbo, Anders Waage, Cyrille Hulin, Meral Beksac, Sonja Zweegman, Philippe Rodon

Haematologica· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-dose vs. high-dose thalidomide for advanced multiple myeloma: a prospective trial from the Intergroupe Francophone du Myélome.
Ibrahim Yakoub-Agha, Jean-Yves Mary, Cyrille Hulin, Chantal Doyen, Gérald Marit, Philippe Rodon

Eur J Haematol· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of melphalan and prednisone plus thalidomide in patients older than 75 years with newly diagnosed multiple myeloma: IFM 01/01 trial.
Cyrille Hulin, Thierry Facon, Philippe Rodon, Brigitte Pegourie, Lotfi Benboubker

J Clin Oncol· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epoetin Beta once-weekly therapy in anemic patients with solid tumors and non-myeloid hematological malignancies receiving chemotherapy.
Dominique Spaëth, Bernard Desablens, Philippe Rodon, Bertrand Mennecier, Stéphane Oudard

Oncology· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The clinical spectrum of IgM-related amyloidosis: a French nationwide retrospective study of 72 patients.
Benjamin Terrier, Arnaud Jaccard, Jean-Luc Harousseau, Richard Delarue, Olivier Tournilhac, Philippe Rodon

Medicine (Baltimore)· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thalidomide versus placebo in myeloid metaplasia with myelofibrosis: a prospective, randomized, double-blind, multicenter study.
Jean-François Abgrall, Isabelle Guibaud, Jean-Noël Bastie, Michel Flesch, Jean-François Rossi, Philippe Rodon

Haematologica· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis